Concepedia

Author

LF Verdonck

Utrecht University

Also Known As

L F Verdonck, L VERDONCK, L Verdonck, L. F. Verdonck, L.F Verdonck, L.F. Verdonck, LF Verdonck, Leo F Verdonck

66

Publications

3K

Citations

28

H-Index

35

Concepts

All Affiliations

Utrecht UniversityErasmus University RotterdamLeiden UniversityUniversity Medical Center UtrechtRadboud University Nijmegen
LV

About

LF Verdonck is an author at Utrecht University specializing in medicine, hematology, and transplantation.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

11

13

617

2

Immunology

5

5

127

3

Blood Transplantation

3

3

308

4

Health Sciences

2

2

92

5

Cellular Therapies

2

2

82

LF Verdonck

×

36

Publications

2.9K

Citations

28

H-Index

YearCitations

Allogeneic bone marrow transplantation versus autologous stem cell transplantation in multiple myeloma: a retrospective case-matched study from the European Group for Blood and Marrow Transplantation

BB Bjorkstrand, Per Ljungman, H. Svensson,

Blood

1996

361

Progress in allogeneic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983–93 and 1994–98 at European Group for Blood and Marrow Transplantation centres

Gösta Gahrton, H. Svensson, Michèle Cavo,

British Journal of Haematology

2001

338

Donor Lymphocyte Infusions for Relapsed Multiple Myeloma After Allogeneic Stem-Cell Transplantation: Predictive Factors for Response and Long-Term Outcome

H M Lokhorst, A Schattenberg, Jan J. Cornelissen,

Journal of Clinical Oncology

2000

287

Graft-versus-myeloma effect in two cases

LF Verdonck, HM Lokhorst, AW Dekker,

The Lancet

1996

242

Prevention of primary cytomegalovirus infection in patients with hematologic malignancies by intensive white cell depletion of blood products

Y.C.E. de Graan‐Hentzen, J. W. Gratama, G.C. Mudde,

Transfusion

1989

186

CHOP Compared With CHOP Plus Granulocyte Colony-Stimulating Factor in Elderly Patients With Aggressive Non-Hodgkin’s Lymphoma

Jeanette K. Doorduijn, Bronno van der Holt, Gustaaf W. van Imhoff,

Journal of Clinical Oncology

2003

168

A randomized study in stage IIIB and IV Hodgkin's disease comparing eight courses of MOPP versus an alteration of MOPP with ABVD: a European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group and Groupe Pierre-et-Marie-Curie controlled clinical trial.

R. Somers, Patrice Carde, M. Henry‐Amar,

Journal of Clinical Oncology

1994

112

Allogeneic bone marrow transplantation with a fixed low number of T cells in the marrow graft [see comments]

LF Verdonck, AW Dekker, GC de Gast,

Blood

1994

88

Cytomegalovirus seronegative platelets and leukocyte-poor red blood cells from random donors can prevent primary cytomegalovirus infection after bone marrow transplantation.

LF Verdonck, Y C de Graan-Hentzen, A. W. Dekker,

PubMed

1987

79

Intensive postremission chemotherapy without maintenance therapy in adults with acute lymphoblastic leukemia. Dutch Hemato-Oncology Research Group.

A. W. Dekker, Mars B. vanʼt Veer, W Sizoo,

Journal of Clinical Oncology

1997

72

Page 1